Cargando…

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Background. Prospective studies about the reversibility of tenofovir disoproxil fumarate- (TDF-) related renal impairment remain scarce. Methods. This is an observational prospective study including all patients that presented at our HIV Unit who interrupted TDF owing to nephrotoxicity. We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonjoch, Anna, Echeverría, Patricia, Perez-Alvarez, Núria, Puig, Jordi, Estany, Carla, Clotet, Bonaventura, Negredo, Eugènia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203893/ https://www.ncbi.nlm.nih.gov/pubmed/28078289 http://dx.doi.org/10.1155/2016/4380845

Ejemplares similares

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study
por: Bonjoch, Anna, et al.
Publicado: (2016)

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
por: Negredo, Eugenia, et al.
Publicado: (2012)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
por: Ramón Santos, José, et al.
Publicado: (2014)

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
por: Juega-Mariño, Javier, et al.
Publicado: (2017)

Ganciclovir–tenofovir interaction leading to tenofovir-induced nephrotoxicity
por: Soanker, Radhika, et al.
Publicado: (2014)

Tenofovir Nephrotoxicity: 2011 Update
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2011)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men
por: Fumaz, Carmina R., et al.
Publicado: (2016)

COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study
por: Echeverría, Patricia, et al.
Publicado: (2020)

Reversal of tenofovir induced nephrotoxicity: case reports of two patients
por: Some, Fatuma, et al.
Publicado: (2017)

Tenofovir alafenamide nephrotoxicity: a case report and literature review
por: Ueaphongsukkit, Thornthun, et al.
Publicado: (2021)

Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients
por: Seo, Jun-Won, et al.
Publicado: (2020)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report
por: Novick, Tessa K., et al.
Publicado: (2017)

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
por: Gupta, Samir K., et al.
Publicado: (2019)

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome
por: Curriu, Marta, et al.
Publicado: (2013)

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Associations between plasma tenofovir concentration and renal function markers in HIV-infected women
por: Mulubwa, Mwila, et al.
Publicado: (2016)

Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media
por: Michael, Ashour, et al.
Publicado: (2014)

Incidence and Risk Factors of Tenofovir Disoproxil Fumarate Induced Nephrotoxicity and Renal Function Recovery, a Hospital Case-Control Study
por: Srisopa, Sirikan, et al.
Publicado: (2023)

Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2014)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Tenofovir-induced renal tubular dysfunction among human immunodeficiency virus patients on antiretroviral therapy in Nigeria: Prospects for early detection of presymptomatic nephrotoxicity
por: Obiebi, Irikefe Paul, et al.
Publicado: (2018)

Isocyanides as Acceptor Groups in MHAT Reactions with Unactivated Alkenes
por: Puig, Jordi, et al.
Publicado: (2023)

Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea
por: Lee, Jeong Eun, et al.
Publicado: (2019)

Prevalence of Nephrotoxicity in HIV Patients Treated with Tenofovir Disoproxil Fumarate: A Single-center Observational Study
por: Hassan, Kowthar Salman, et al.
Publicado: (2019)

Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study
por: Hassan, Muzamil O., et al.
Publicado: (2020)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Renal Dysfunction due to Tenofovir-Diphosphate Inhibition of Mitochondrial Complex V (ATP Synthase)
por: Sluis-Cremer, Nicolas
Publicado: (2023)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
por: Funderburg, Nicholas T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fs0p6s18dsp47bvjpo7ik9eb2s